HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combined sphingosine, S1P and ischemic postconditioning rescue the heart after protracted ischemia.

Abstract
Both sphingosine and sphingosine-1-phosphate (S1P) were able to protect the ex vivo rat heart from ischemia reperfusion injury when added to the perfusion medium at the time of reperfusion after a 40min ischemia (postconditioning). Inhibitor studies revealed distinct mechanisms of protection, with S1P employing a G-protein coupled receptor pathway and sphingosine a cyclic nucleotide dependent protein kinase pathway. However, both restored ischemia-induced depletion of phospho-AKT. Extending the ischemia to 75min reduced protection by both S1P and sphingosine, but protection could be enhanced by employing them in combination. Extending the time of ischemia further to 90min almost eliminated cardioprotection by S1P or sphingosine; and their combination gave only modest protection. However, when S1P plus sphingosine was combined with a novel ramped ischemic postconditioning regimen, left ventricle developed pressure recovered by 66% and there was only a 6% infarct size. The data indicate that detrimental changes are accumulating during protracted ischemia but for up to 90min this damage is not irreversible and hearts can still recover with proper treatment.
AuthorsDonald A Vessey, Luyi Li, Michael Kelley, Joel S Karliner
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 375 Issue 3 Pg. 425-9 (Oct 24 2008) ISSN: 1090-2104 [Electronic] United States
PMID18706887 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Cardiotonic Agents
  • Lysophospholipids
  • Receptors, G-Protein-Coupled
  • sphingosine 1-phosphate
  • Proto-Oncogene Proteins c-akt
  • Sphingosine
Topics
  • Animals
  • Cardiotonic Agents (pharmacology)
  • Coronary Vessels (drug effects, physiopathology)
  • Heart Ventricles (drug effects, metabolism, physiopathology)
  • In Vitro Techniques
  • Lysophospholipids (pharmacology)
  • Phosphorylation
  • Proto-Oncogene Proteins c-akt (antagonists & inhibitors, metabolism)
  • Rats
  • Receptors, G-Protein-Coupled (metabolism)
  • Reperfusion Injury (metabolism, physiopathology)
  • Signal Transduction (drug effects)
  • Sphingosine (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: